Anti-inflammatory effect of Qingwen Baidu Decoction (清瘟败毒饮) in sepsis rats

Chinese Journal of Integrative Medicine

Volumn 20, Issue 12, 2014, Pages 934-943

  Yu, Zheng Miao ^a   Liu, Zhi Hui ^a   Chen, Jing ^b   Zeng, Qiang ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b GUANGDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Chinese medicine; cytokine; mediator network; Qingwen Baidu Decoction; sepsis; summer heat syndrome

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PLANT EXTRACT; QINGWEN BAIDU DECOCTION; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; CYTOKINE; HERBACEOUS AGENT; QINGWEN BAIDU;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LOW DRUG DOSE; MEDIATOR; MEDIATOR RELEASE; NONHUMAN; POLYMERASE CHAIN REACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; UPREGULATION; WESTERN BLOTTING; AGAR GEL ELECTROPHORESIS; ANIMAL; CELL LINE; DNA DENATURATION; DRUG EFFECTS; LUNG; MALE; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CELL LINE; CYTOKINES; DRUGS, CHINESE HERBAL; ELECTROPHORESIS, AGAR GEL; INFLAMMATION MEDIATORS; LUNG; MALE; NUCLEIC ACID DENATURATION; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS;

EID: 84919764058     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-014-1863-x     Document Type: Article

References (25)

1. Gazin V, Kerdine S, Grillon G, Pallardy M, Raoul H. Uranium induces TNF alpha secretion and MAPK activation in a rat alveolar macrophage cell line. Toxicol Appl Pharmacol 2004;194:49–59.
2. Helmke RJ, German VF, Mangos JA. A continuous alveolar macrophage cell line: comparisons with freshly derived alveolar macrophages. In Vitro Cell Dev Biol 1989;25:44–48.
3. Deitch EA, Redl H, Schlag G, Bahrami S. Animal models of sepsis and shock: a review and lessons learned. Shock 1998;9:1–11.
4. Watson J, Riblet R, Taylor BA. The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol 1997;118:2088–2093.
5. Yu ZM, Liu ZH, Chen J, Zhu HL. Influence of decoction for clearing away pestilent factors and detoxification on inflammatory mediators in summer heat syndrome rats of epidemic febrile disease. Pharmacol Clin Chin Mater Med (Chin) 2010;28:286–288.
6. Yu ZM, Xu QW, Pang ZY, Zhou XJ, Li XJ. Endueing summer heat syndrome rat model of epidemic febrile disease by lipopolysaccharide infusion and high temperature environment. J Liaoning Univ Chin Med (Chin) 2010;12:18–20.
7. Yu ZM, Chen J, Liu ZH, Zhu HL, Zhong JX. Influence of decoction for clearing away pestilent factors and detoxification on IL-1, 6, 10, 18, TNF-α, IFN-γ of rabbits with systemic inflammatory response syndrome. Pharmacol Clin Chin Mater Med (Chin) 2009;25:3–6.
8. Jiang JX, ed. Bacterial endotoxin and clinic. Beijing: People’s Military Medical Press; 2004:188–189.
9. Dinarello CA. Proinflammatory cytokines. Chest 2000;118:503–508.
10. Mazolewski PJ, Barber A, Williams S, Simoni J, Davis S, Shires GT. Attenuating tumor necrosis factor alpha does not ameliorate other cytokine and peroxidase products during sepsis. Am J Surg 1999;178:556–559.
11. Pestaña D, Casanova E, Villagrán MJ, Tormo C, Pérez-Chrzanowska H, Redondo J, et al. Continuous hemofiltration in hyperthermic septic shock patients. J Trauma 2007;63:751–756.
12. Page M, Hayi-Slayman D, Ber CE, Christin F, Baillon JJ, Bret M, et al. Use of coupled plasma filtration adsorption for septic shock treatment. Ann Fr Anesth Reanim 2007;26:990–993.
13. Patel GP, Balk RA. Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med 2012;185:133–139.
14. Sprung CL, Brezis M, Goodman S, Weiss YG. Corticosteroid therapy for patients in septic shock: some progress in a difficult decision. Crit Care Med 2011;39:571–574.
15. Branca M. Genetics and medicine: putting gene arrays to the test. Science 2003;300:238.
16. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 2004;116:511–526.
17. Sze SK, de Kleijn DP, Lai RC, Tan EK, Zhao H, Yeo KS, et al. Elucidating the secretion proteome of human ESCderived mesenchymal stem cells. Mol Cell Proteomics 2007;6:1680–1689.
18. Wingren C, Borrebaeck CA. Antibody-based microarrays. Methods Mol Biol 2009;509:57–84.
19. Uhlén M, Björling E, Agaton C, Szigyarto CA, Amini B. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteom 2005;4:1920–1932.
20. Celis JE, Moreira JM, Cabezón T, Gromov P, Friis E, Rank F, et al. Identification of extracellular and intracellular signaling components of the mammary sdipose tissue and its interstitial fluid in high risk breast cancer patients. Molecul Cell Proteom 2005;4:492–522.
21. Carlsson A, Persson O, Ingvarsson J, Widegren B, Salford L, Borrebaeck CA, et al. Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients. Proteomics Clin Appl 2010;4:591–602.
22. Lindskog C, Asplund A, Engkvist M, Uhlen M, Korsgren O, Ponten F. Antibody-based proteomics for discovery and exploration of proteins expressed in pancreatic islets. Discov Med 2010;9:565–578.
23. Hu H, Kwun J, Aizenstein BD, Knechtle SJ. Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines inurine. Transplantation 2009;87:1814–1820.
24. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006;116:3183–3194.
25. Aubin E, Lemieux R, Bazin R. Absence of cytokine modulation following therapeutic infusion of intravenous immunoglobulin or anti-red blood cell antibodies in a mouse model of immune thrombocytopenic purpura. Br J Haematol 2007;136:837–843.